Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Candesant Biomedical Inc. is currently prosecuting a patent portfolio within the Medical Devices & Mechanical Engineering technology area. The company has 1 pending office action, which is being reviewed by 1 distinct examiner. This focus suggests a highly specific or early-stage prosecution phase for the current filings. The concentration of effort within a technical domain allows for a focused legal strategy but limits the breadth of examiner feedback at this time.
The activity is concentrated within a distinct art unit, aligning with the pending action and examiner. The busiest examiner, DEMIE, TIGIST S, is handling the pending office action. Because this examiner is responsible for the only pending action in the portfolio, the company's immediate strategy must be tailored to the specific requirements of this examiner. The lack of multiple art units or examiners indicates that the current pending workload does not yet span a broad technical or administrative range within the patent office. Consequently, the company's prosecution success is currently tied to the individual review process of the examiner within the Medical Devices & Mechanical Engineering sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEMIE, TIGIST S | 1 | 75.2% | +20.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18786421 | MEDICAL DEVICES FOR GENERATING HEAT AND METHODS OF TREATMENT USING THE SAME | DEMIE, TIGIST S | — |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18786421 | MEDICAL DEVICES FOR GENERATING HEAT AND METHODS OF TREATMENT USING THE SAME | DEMIE, TIGIST S | 3794 | §103§112DP | Non-Final OA | — | Pending | Jul 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCandesant Biomedical Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Tigist S Demie has the most, with 1 of Candesant Biomedical Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.